POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

The paper discusses data on the high frequency of non-indicated use of proton pump inhibitors and on the manifestations of potential harms of their use.

Opis bibliograficzny
Główni autorzy:	Yu. V. Muravyev, O. R. Bobkova
Format:	Artykuł
Język:	Russian
Wydane:	IMA PRESS LLC 2018-11-01
Seria:	Научно-практическая ревматология
Hasła przedmiotowe:	proton pump inhibitors harm rheumatoid arthritis hypersensitivity reactions
Dostęp online:	https://rsp.mediar-press.net/rsp/article/view/2634

Podobne zapisy

Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs
od: S I Pimanov, i wsp.
Wydane: (2015-04-01)

Proton pump inhibitors overuse - consequences among patients
od: Patrycja Kmiotek, i wsp.
Wydane: (2019-08-01)

Proton pump inhibitors overuse - consequences among patients
od: Patrycja Kmiotek, i wsp.
Wydane: (2019-08-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
od: Mario Visconti
Wydane: (2015-09-01)

Proton Pump Inhibitors and Gastric Cancer
od: Seungkyung Kang, i wsp.
Wydane: (2021-09-01)

Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
od: S.M. Tkach
Wydane: (2014-02-01)

Proton pump inhibitor alters Th17/Treg balance and induces gut dysbiosis suppressing contact hypersensitivity reaction in mice
od: Anna Strzępa, i wsp.
Wydane: (2024-08-01)

Omeprazole was safely reused in a rhabdomyolysis patient associated with proton pump inhibitors: A case report
od: Zhen Wang, i wsp.
Wydane: (2023-11-01)

Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients
Wydane: (2016-01-01)

Deprescribing of Inappropriately Consumed Proton Pump Inhibitors and its Clinical Consequences
od: Apoorva Rachana Kulkarni, i wsp.
Wydane: (2021-08-01)

Proton pump inhibitors to control phosphorus levels in hemodialysis patients
od: Amineh Hojati
Wydane: (2025-10-01)

Incidence of hypomagnesemia on proton pump inhibitors at the Huntington Veterans Affairs Medical Center – IHOP
od: Ebrahim Sabbagh, i wsp.
Wydane: (2016-07-01)

Proton pump inhibitors and dementia: what association?
od: Catarina Caetano, i wsp.
Wydane: (2023-05-01)

Proton pump inhibitors usage and the risk of cancer
od: Hubert Wróblewski, i wsp.
Wydane: (2021-08-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
od: V. O. Kaybysheva, i wsp.
Wydane: (2011-06-01)

Proton Pump Inhibitors: Are They a Real Threat to the Patient?
od: Sofia Xavier, i wsp.
Wydane: (2018-02-01)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
od: Cahir Caitriona, i wsp.
Wydane: (2012-11-01)

A dual role of proton pump inhibition on cancer: a critical review
od: Edizer Deniz Tuna, i wsp.
Wydane: (2023-02-01)

PPI adverse drugs reactions: a retrospective study
od: Marco Casciaro, i wsp.
Wydane: (2019-01-01)

Proton pump inhibitors induce hemolytic anemia
od: Asayil Nasser Al-Nasser, i wsp.
Wydane: (2019-01-01)

Effects of proton pump inhibitor use on the esophageal microbial community
od: Sadia Tasnim, i wsp.
Wydane: (2020-09-01)

Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
od: Verónica Gamelas, i wsp.
Wydane: (2018-05-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
od: Byungkyu Ahn, i wsp.
Wydane: (2016-07-01)

Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients
od: Su Yeong Kim, i wsp.
Wydane: (2019-10-01)

Proton-pump inhibitors
od: Vasudevan G. Naidoo
Wydane: (2015-05-01)

The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia
od: Yong Ting Tai, i wsp.
Wydane: (2020-04-01)

Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
od: Tae Jun Kim, i wsp.
Wydane: (2020-09-01)

Proton-pump Inhibitors and the Risk of Dementia: A Systematic Review and Meta-analysis
od: Kyu-Tae Yoon, i wsp.
Wydane: (2021-06-01)

Meniere’s disease and the use of proton pump inhibitors
od: A Pirodda, i wsp.
Wydane: (2010-09-01)

METHOTREXATE AND PROTON PUMP INHIBITORS: ARE THERE ANY NEGATIVE PHARMACOLOGIAL EFFECTS?
od: Andrey E Karateev, i wsp.
Wydane: (2014-02-01)

25 Years of Proton Pump Inhibitors: A Comprehensive Review
od: Daniel S. Strand, i wsp.
Wydane: (2017-01-01)

Proton pump inhibitors and risk for Clostridium difficile associated diarrhea
od: Sasmita Biswal
Wydane: (2014-08-01)

The effect of proton pump inhibitors on glycaemic control in diabetic patients
od: Muhammad Ali Rajput, PhD, i wsp.
Wydane: (2020-06-01)

Pointing the finger at proton pump inhibitors
od: Emma L Walton
Wydane: (2014-08-01)

Proton pump inhibitor deprescription: A rapid review
od: Renata Rodriguez Imparato, i wsp.
Wydane: (2022-07-01)

Pharmacogenetics of proton pump inhibitors
od: M. V. Leonova
Wydane: (2015-12-01)

Potential adverse effects of long term use of Proton Pump Inhibitors
od: Shreyans M. Doshi, i wsp.
Wydane: (2016-07-01)

Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
od: Sang-Ho Park, i wsp.
Wydane: (2015-06-01)

The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
od: Dania Tawam, i wsp.
Wydane: (2021-03-01)

Anaphylaxis as a Rare Side Effect of Pantoprazole; a Case Report
od: Gholamreza Faridaalaee, i wsp.
Wydane: (2018-05-01)